Jane Street’s Haemonetics HAE Stock Holding History

Jane Street’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$265K	Buy	+4,700	New	+$306K	﹤0.01%	9501
2025 Q4	–	Sell	-21,800	Closed	-$1.06M	–	11635
2025 Q3	$1.06M	Buy	21,800 +19,000	+679%	+$1.18M	﹤0.01%	6184
2025 Q2	$209K	Buy	+2,800	New	+$185K	﹤0.01%	8469
2025 Q1	–	Sell	-15,000	Closed	-$1.17M	–	9876
2024 Q4	$1.17M	Buy	+15,000	New	+$1.2M	﹤0.01%	5073
2023 Q2	–	Sell	-6,900	Closed	-$571K	–	9031
2023 Q1	$571K	Buy	+6,900	New	+$559K	﹤0.01%	6104
2022 Q1	–	Sell	-5,100	Closed	-$271K	–	10578
2021 Q4	$271K	Sell	5,100 -3,700	-42%	-$225K	﹤0.01%	8360
2021 Q3	$621K	Buy	8,800 +1,000	+13%	+$63.1K	﹤0.01%	6863
2021 Q2	$520K	Buy	+7,800	New	+$552K	﹤0.01%	7161
2020 Q3	–	Sell	-14,500	Closed	-$1.3M	–	7438
2020 Q2	$1.3M	Buy	+14,500	New	+$1.46M	﹤0.01%	3688

Other funds holding HAE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jane Street's HAE Position: Q1 2026 in Review

Jane Street reduced its Haemonetics (HAE) stake by 71% in Q1 2026, selling an estimated $24.3M and leaving 152,958 shares worth $8.62M. The position accounts for ﹤0.01% of the portfolio, ranked #2725.

Jane Street first reported a position in HAE in Q4 2013 and has held it in 30 quarters since. The position peaked at $42.2M in Q4 2025. 324 funds tracked by Wall St. Rank hold HAE as of Q1 2026.

Jane Street held 152,958 shares of Haemonetics worth $8.62M as of Q1 2026.
Jane Street sold 373,329 Haemonetics shares in Q1 2026, an estimated $24.3M.
Haemonetics made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #2725 holding.
Jane Street first reported a position in Haemonetics in Q4 2013 and has held it in 30 quarters since.
Jane Street's Haemonetics position peaked at $42.2M in Q4 2025.
324 funds tracked by Wall St. Rank held Haemonetics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.